Drop in mortality seen with AChEI, memantine in dementia with lewy bodies

AI background business technology, digital transformation

For patients with dementia with Lewy bodies (DLB), treatment with acetylcholinesterase inhibitors (AChEIs) and/or memantine is associated with reduced hospital admissions and mortality, according to a study published online Dec. 6 in PLOS Medicine.

Grab a pair of Beats Studio Buds for their lowest price yet

Previous article

States that restrict abortions have more maternal, infant deaths

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations